Introduction
Medical device registration in India is the structured regulatory and operational function through which a business determines whether a product is regulated as a medical device, identifies the applicable Indian risk class and secures the correct import or manufacturing pathway required for lawful commercialization.
In practical terms, India combines the Medical Devices Rules, 2017, class-based regulation from A to D, online application handling through the Sugam system and detailed master-file documentation requirements for imported and locally manufactured devices.
The subject is commercially important because India is a large and growing medtech market, while mistakes around class, import-license structure, authorized-agent appointment, predicate strategy or master-file completeness can delay or block lawful market entry.
Home
└── Jurisdictions
└── India
└── Medical Device Registration India
Identity
- Object: Medical Device Registration
- Jurisdiction: India
- Object ID: IN.MDR.001
- Reference: MAR-IN-MDR-001-A
Core Framework
- CDSCO-centered device regulation
- Medical Devices Rules, 2017
- Risk Classes A, B, C and D
- Import licensing and manufacturing licensing through prescribed forms
Operating Logic
- Risk-based regulation drives route and review depth
- Imported devices use authorized-agent and import-license structure
- DMF and PMF are central in imported-device dossiers
- Predicate, safety, performance and vigilance evidence are recurring themes
Executive Summary
Medical device registration in India is the professional regulatory and market-access function concerned with determining whether a product falls within the Indian medical-device framework, identifying its risk class and securing the correct CDSCO pathway for lawful commercialization.
India regulates all medical devices under the Drugs & Cosmetics Act, 1940 and the Medical Devices Rules, 2017. CDSCO explains that medical devices are classified into four classes based on risk: Class A, Class B, Class C and Class D.
The pathway is therefore class-driven. CDSCO also explains that applicants use prescribed forms through the Sugam online portal for import licenses, manufacturing licenses, test licenses, clinical investigation permissions and new-device permissions.
For imported medical devices, the authorized-agent and import-license structure is central. CDSCO’s MD-15 checklist requires an application in Form MD-14 and mandates documents such as a Power of Attorney from the foreign manufacturer, authorized-agent details, regulatory certificates, quality-system certificates, the Plant Master File and the Device Master File.
| Definition | The professional regulatory and market-access function concerned with securing the lawful Indian import or manufacturing position for medical devices through classification, licensing strategy, authorized-agent structure and documentary readiness. |
| Object | Medical Device Registration |
| Object Type | Professional Regulatory and Market-Access Function |
| Classification | Medical Devices, India, CDSCO, Medical Devices Rules 2017, Class A, Class B, Class C, Class D, MD-14, MD-15, Authorized Agent, DMF, PMF |
| Jurisdiction | India |
Definition
Medical device registration in India refers to the structured process through which a business determines whether its product is regulated as a medical device in India, identifies the relevant risk class and secures the appropriate import or manufacturing pathway before commercialization.
The object is broader than filing an online application. It covers device qualification, class mapping, import-versus-manufacturing strategy, authorized-agent structure, predicate positioning, device and plant master files, quality evidence, labeling readiness and post-approval maintenance.
| Covered Matters | Device qualification, class determination, import versus manufacturing strategy, authorized-agent structuring, DMF and PMF preparation, quality-system support, predicate positioning, labeling, clinical evidence and lifecycle maintenance. |
| Functional Boundary | The Registry Object covers how businesses achieve and maintain lawful Indian market access for medical devices. |
| Related but Not Primary | Public procurement, reimbursement, distributor contracting, patent strategy and broader healthcare commercialization are adjacent but not the primary object here. |
| Outside Scope | Pharmaceutical-only approvals, unrelated consumer-product regulation, general company formation and broad tax planning. |
Scope
The Indian medical device registration function applies to products regulated as medical devices under the Medical Devices Rules, 2017 and to the companies responsible for lawfully importing or manufacturing those devices for sale or distribution.
The scope is both product-facing and structure-facing. CDSCO’s medical-device portal shows separate functions for import licensing, manufacturing licensing, test licensing, clinical investigation permissions and permissions for devices without predicate devices.
Editorial Note: In India, a registration review is incomplete if it looks only at the product class and ignores whether the business is entering through import licensing, manufacturing licensing, investigational permissions or a no-predicate pathway.
Purpose
The purpose of medical device registration in India is to convert a product, technical file and commercialization plan into a lawful CDSCO market-entry position.
In business terms, the function exists to identify the correct class-based route, determine whether the product requires import licensing or manufacturing licensing, align the Indian authorized-agent or local manufacturer structure and reduce the risk of entering India on an unsupported regulatory assumption.
Primary Outcome
A coherent Indian medical device registration position means that the device has been qualified correctly, matched to the applicable Class A, B, C or D category and linked to the correct CDSCO route for lawful commercialization.
Depending on the route, the outcome may be an import license, a manufacturing license, a test license, a clinical-investigation permission or a permission for a device without a predicate device. CDSCO’s public medical-device portal lists these pathways as active regulatory functions within the Indian framework.
Request Contexts
Request contexts show the business situations in which Indian registration work is usually activated. Most begin before launch, but the function is also relevant in import-license retention, endorsement applications, device additions and post-approval change work.
| Identity Pattern | Manufacturer planning Indian entry, foreign manufacturer evaluating authorized-agent options, regulatory lead reviewing CDSCO classification, local Indian entity assessing import-license obligations, investor validating Indian authorization architecture. |
| Business Event | First Indian launch, class uncertainty, import-license strategy, manufacturing-license planning, DMF or PMF preparation, predicate uncertainty, clinical investigation planning, retention or endorsement application. |
| Typical User | Manufacturers, authorized agents, importers, Indian legal entities, regulatory affairs managers, legal advisers, investors and international medtech businesses. |
| Typical Scenario | A company needs to determine whether its product follows an Indian import-license route or a manufacturing route, which class applies, what dossier structure is needed and how the authorized-agent relationship should be documented. |
Typical Users
Different actors encounter Indian registration from different positions, but the common issue is the need for a defensible answer on class, route and Indian legal structure.
| Foreign Manufacturer | Needs to determine class, route, Indian authorized-agent structure and whether the imported-device dossier is complete enough for MD-14 and MD-15 licensing. |
| Indian Authorized Agent | Needs to hold the documentary authority to represent the foreign manufacturer and support import licensing and regulatory communication. |
| Regulatory Affairs Lead | Needs to align class, predicate strategy, DMF, PMF, labeling, safety and performance documentation with the Medical Devices Rules framework. |
| Quality or Operations Lead | Needs to ensure manufacturing-site and quality-system materials can support Indian licensing expectations. |
| Commercial Team | Needs to understand whether the product can launch under the intended import or manufacturing structure and whether additional investigation or no-predicate permissions are needed. |
Typical Scenarios
Practical scenarios show where Indian registration analysis becomes operationally important.
| Initial Qualification | The business must determine whether the product is regulated as a medical device in India under the Medical Devices Rules, 2017. |
| Class Strategy | The company needs to determine whether the device falls into Class A, B, C or D, because that drives the route and the review depth. |
| Import License Route | The manufacturer needs to assess whether the imported product requires application in MD-14 for grant of import license in MD-15. |
| Manufacturing Route | The business needs to determine whether it must proceed through manufacturing-license forms such as MD-7 and MD-8 for Class C or D manufacturing pathways. |
| No-Predicate Strategy | The company needs to determine whether the device lacks a predicate and therefore requires a separate permission route after clinical investigation. |
| Retention or Endorsement Work | The business needs to maintain existing licenses, add products or support retention filings with updated surveillance and documentary undertakings. |
Jurisdiction Characteristics
India is a CDSCO-centered medical-device jurisdiction with strong reliance on formal risk classes, prescribed form-based applications and documentary master files for imported devices.
A distinctive practical feature is the detail of the import-license checklist. CDSCO’s MD-15 checklist requires an authenticated Power of Attorney, free-sale or marketing-authorization evidence, overseas establishment evidence, quality certificates, a Plant Master File, a Device Master File and extensive technical sections such as substantial equivalence, risk analysis, labeling, software validation, clinical evidence and vigilance data.
| Operational Culture | Formal, form-based and strongly structured around documentary completeness. |
| Legal Framework Orientation | CDSCO-led licensing system built around Medical Devices Rules, 2017, classification, licensing forms and master-file documentation. |
| Commercial Context | Large growth market where compliant local representation and dossier completeness are decisive. |
| Language Expectation | English-language regulatory materials are commonly used at the central level, while practical market entry still depends on accurate local documentation and process management. |
Key Authorities
Indian medical device registration is centered on the Central Drugs Standard Control Organisation. CDSCO’s public device portal explains that it handles medical-device classification, import licensing, manufacturing licensing, clinical-investigation permissions and related medical-device regulatory functions.
| Official Name | Central Drugs Standard Control Organisation |
| Official English Name | Central Drugs Standard Control Organisation (CDSCO) |
| Primary Role | National authority responsible for medical-device regulatory administration in India. |
| Responsibilities | Defines and administers medical-device classification, import licensing, manufacturing licensing, clinical-investigation permissions, testing-laboratory registration and related regulatory processes. |
| Typical Interaction | Direct where a business needs class determination, import-license analysis, manufacturing-license planning, no-predicate strategy, clinical investigation permission or post-approval change handling. |
| Official Website | CDSCO Medical Device & Diagnostics |
| Cross-Border Relevance | High, because foreign manufacturers depend on Indian authorized-agent and import-license structures to commercialize imported devices in India. |
Applicable Legislation
The Indian framework combines the Drugs & Cosmetics Act, 1940 with the Medical Devices Rules, 2017 and detailed prescribed forms, schedules and guidance documents. CDSCO’s public portal presents the Medical Devices Rules, 2017 as the central operative rules for regulation of medical devices in India.
| Official Title | Medical Devices Rules, 2017 |
| Year | 2017 |
| Purpose | Provides the legal framework for classification, import licensing, manufacturing licensing, test licensing, clinical investigations and related medical-device permissions in India. |
| Typical Application | Used to determine whether a device follows import, manufacturing, investigation or no-predicate pathways and what forms and schedules govern the route. |
| Related Legislation | Drugs & Cosmetics Act, 1940 and associated schedules, forms and guidance documents. |
| Official Source | CDSCO Medical Device & Diagnostics |
| Current Status | Active framework. |
| Official Title | Import License Checklist for Form MD-15 under Medical Devices Rules, 2017 |
| Year | Current CDSCO checklist document |
| Purpose | Specifies documentary requirements for grant, endorsement and retention of import licenses for medical devices. |
| Typical Application | Used when preparing import-license applications in MD-14 and receiving or retaining licenses in MD-15. |
| Related Legislation | Medical Devices Rules, 2017 and the Fourth Schedule requirements for PMF and DMF. |
| Official Source | CDSCO MD-15 Checklist |
| Current Status | Active documentary reference. |
Process Flow
Indian medical device registration normally works as a staged process from product qualification to commercialization. CDSCO’s medical-device framework starts with classification and then links the product to import, manufacturing, testing, investigation or new-device permission pathways depending on product profile.
| 1. Product Qualification | Determine whether the product is regulated as a medical device in India. |
| 2. Risk Classification | Identify the applicable Class A, B, C or D category. |
| 3. Route Determination | Determine whether the product follows import licensing, manufacturing licensing, test licensing, clinical investigation or no-predicate permission pathways. |
| 4. Authorized-Agent or Local Structure | Align the Indian authorized agent or local manufacturer structure needed to support the route. |
| 5. Dossier Preparation | Prepare the Device Master File, Plant Master File, regulatory certificates, quality documents and technical evidence needed for the route. |
| 6. Online Submission | Submit the required application through the Sugam portal using the prescribed form. |
| 7. Review and Deficiency Handling | Address documentary scrutiny, clarifications, inspections or additional evidence requests where required. |
| 8. License or Permission Grant | Proceed to commercialization only after the relevant Indian license or permission is in place. |
| 9. Retention and Maintenance | Maintain surveillance, endorsements, retention filings and post-approval obligations after launch. |
| Typical Outputs | Qualification memo, class rationale, route memo, authorized-agent file, DMF, PMF, application file, granted license and maintenance file. |
Decision Tree
The decision tree helps simplify the main Indian threshold questions.
- Confirm whether the product is regulated as a medical device in India.
- Determine the risk class because India uses four classes from A to D.
- Establish whether the business is entering through import licensing or manufacturing licensing.
- If the product is imported, determine who will serve as the Indian authorized agent and whether the MD-14 to MD-15 route is the correct pathway.
- Prepare the Device Master File, Plant Master File and supporting regulatory and quality documentation.
- Assess whether the product has a predicate device or whether a no-predicate permission route may be necessary.
- Assess whether clinical investigation or test-license permissions are required before commercialization.
- Commercialize only after the correct Indian license or permission position is secured.
Timeline
The Indian timeline begins before launch and continues after commercialization. The exact route depends on risk class, import-versus-manufacturing structure, predicate position, documentary completeness and whether investigation or no-predicate permissions are triggered.
| Concept Stage | The business defines the product, intended use and Indian market objective. |
| Qualification Stage | The product is assessed to determine whether it is a medical device under Indian rules. |
| Classification Stage | The risk class is mapped because it determines the route and review depth. |
| Structure Stage | The Indian authorized-agent or local manufacturing structure is formalized. |
| Dossier Stage | The business prepares the DMF, PMF and supporting regulatory and quality documents. |
| Submission Stage | The application is submitted through Sugam in the relevant prescribed form. |
| Grant Stage | The import license, manufacturing license, test license or permission is granted after review. |
| Maintenance Stage | The business manages endorsements, retention, vigilance and post-approval changes. |
Required Documents
The exact document set depends on class and pathway, but Indian medical device registration depends on a coherent documentary file that supports classification, route selection and licensing readiness.
| Document | Product Qualification and Classification Record |
| Purpose | Explains why the product is regulated as a medical device in India and what class applies. |
| Typical Situation | Prepared at the beginning of Indian registration strategy. |
| Document | Power of Attorney and Authorized-Agent File |
| Purpose | Documents the Indian authorized agent and the authority to represent the foreign manufacturer for imported-device licensing. |
| Typical Situation | Used whenever a foreign manufacturer plans Indian import licensing. |
| Document | Plant Master File |
| Purpose | Provides manufacturing-site information in the format required by the Medical Devices Rules, 2017. |
| Typical Situation | Used in imported-device dossiers and related licensing work. |
| Document | Device Master File |
| Purpose | Provides device-level technical, safety, performance, equivalence, labeling and vigilance information required for review. |
| Typical Situation | Used in import-license applications and related product submissions. |
| Document | Regulatory and Quality Certificates File |
| Purpose | Supports free-sale status, overseas establishment status, quality-system evidence and declarations of conformity. |
| Typical Situation | Used in import-license grant, endorsement and retention applications. |
Cross-Border Relevance
Cross-border relevance is high because many non-Indian manufacturers rely on Indian authorized agents and import-license structures to enter the market. CDSCO’s MD-15 checklist requires a Power of Attorney and undertaking from the authorized agent, along with constitution details and license evidence for the authorized agent.
The cross-border issue is therefore not simply whether the product is approved elsewhere. It is whether the manufacturer has mapped the Indian class, import-license route, authorized-agent structure, free-sale evidence and DMF-PMF documentation required by CDSCO.
| Recognition | Indian market access depends on CDSCO compliance rather than automatic recognition of foreign device approvals. |
| Foreign Companies | Foreign manufacturers must structure entry through Indian authorized-agent and import-license arrangements. |
| Language Considerations | English-language central regulatory documentation is widely used, but practical compliance still depends on accurate local process handling. |
| International Rules | Cross-border businesses must treat authorized-agent documentation, free-sale evidence and master-file preparation as core workstreams. |
| Practical Considerations | Indian entry strategy should treat class, route, local representative structure and documentary readiness as one integrated architecture. |
| Typical Risk | Assuming a foreign manufacturer can enter India with only foreign-market approvals and without a complete authorized-agent, DMF, PMF and import-license architecture. |
CDSCOMedical Devices Rules 2017Class A-DMD-14MD-15Authorized AgentDMFPMF
Operating Constraints & Risks
Operating constraints identify the recurring failure points in Indian medical device registration. Many arise when businesses underestimate how central the authorized-agent and master-file structure is.
| Qualification Risk | The product is misread as a medical device or non-device under Indian rules. |
| Class Risk | The wrong class is assumed, leading to the wrong route or incorrect expectations about scrutiny. |
| Authorized-Agent Risk | The Indian representative structure is not properly documented before import-license filing. |
| Documentary Risk | The DMF, PMF or supporting regulatory certificates are incomplete, inconsistent or not properly authenticated. |
| Predicate Risk | The business assumes the device has a predicate when a no-predicate route may actually apply. |
| Investigation Risk | Clinical investigation or test-license requirements are overlooked until late in the process. |
| Maintenance Risk | Retention, endorsement, vigilance and post-approval obligations are not managed after launch. |
Costs & Fees
Indian medical device registration costs arise from several separate components rather than one single filing step. Class strategy, authorized-agent structure, master-file preparation, authentication work and supporting evidence can all affect the cost profile.
| Assessment Costs | Classification analysis, route planning and Indian regulatory strategy can be substantial depending on device complexity. |
| Authorized-Agent Costs | The Indian authorized-agent model often creates recurring commercial and compliance cost because it is central to imported-device market access. |
| Dossier Costs | Preparing the Device Master File, Plant Master File and supporting regulatory package can generate meaningful direct and indirect project cost. |
| Authentication Costs | Notarization, apostille and related document-authentication steps can add cost and delay. |
| Investigation Costs | Where clinical investigation or no-predicate pathways are triggered, the evidence burden can increase project cost significantly. |
| Maintenance Costs | Retention, endorsements, surveillance and post-approval changes create ongoing expense after launch. |
FAQ
The FAQ section addresses recurring threshold questions in Indian market-entry work.
| Who Regulates Medical Devices in India? | Medical devices in India are regulated by CDSCO under the Drugs & Cosmetics Act, 1940 and the Medical Devices Rules, 2017. |
| How Many Device Classes Does India Use? | India uses four risk classes: Class A, Class B, Class C and Class D. |
| What Is the Main Import-License Route? | CDSCO states that the applicant makes an application in MD-14 on the Sugam portal for grant of import licence in MD-15. |
| Is an Authorized Agent Required for Imported Devices? | For foreign manufacturers using the import route, the CDSCO checklist requires a Power of Attorney and undertaking from the authorized agent, which makes the authorized-agent structure a core part of the dossier. |
| What Are DMF and PMF? | They are the Device Master File and Plant Master File required under the Medical Devices Rules framework for imported-device licensing and related submissions. |
| Does India Have Routes for Investigational or No-Predicate Devices? | Yes. CDSCO lists separate permissions for clinical investigation and for import or manufacture of a medical device that does not have its predicate device. |
Practical Guidance
Practical guidance helps a business prepare before finalising an Indian market-entry strategy.
| Checklist | What exactly is the product under Indian law? What risk class applies? Is the route import licensing, manufacturing licensing, test licensing, clinical investigation or a no-predicate permission? If the product is imported, who will serve as the Indian authorized agent? Has the Power of Attorney been authenticated properly? Are the Device Master File and Plant Master File complete? Are free-sale evidence, regulatory certificates, establishment documents and quality certificates in place? Does the product have a defensible predicate position? Could clinical investigation or MD-27 style no-predicate permission be required? Are retention, endorsement and vigilance responsibilities clearly allocated? |
A disciplined Indian registration review should start with class and route architecture. In many failed launches, the visible filing problem is only a later symptom of an earlier error about authorized-agent structure, predicate strategy, documentary authentication or the completeness of the DMF and PMF package.
Jurisdictional Expert
The Jurisdictional Expert section records the status of the registry position associated with this jurisdictional object. It remains separate from the editorial content.
| Registry Position ID | RE-IN-MDR-001 |
| Registry Position | Jurisdictional Expert Medical Device Registration India |
| Registry Availability | Open |
| Verification Status | No verified participant currently assigned to this registry position. |
| Coverage | India medical device registration with emphasis on CDSCO class logic, Medical Devices Rules 2017, import licensing, authorized-agent structure, DMF-PMF preparation and related investigational or no-predicate pathways. |
| Registry Reference | MAR-IN-MDR-001-A Jurisdictional Expert Position |
| Contact Information | Registry position not yet assigned. |
Machine Layer
This section contains machine-oriented registry fields retained for indexing, retrieval, system organisation and future rendering control. It may be visually minimised while remaining fully available in the HTML source.
| Object DNA | medical device registration india cdsco medical devices rules 2017 class a class b class c class d md-14 md-15 authorized agent import license device master file plant master file predicate market access |
| AI Retrieval Summary | Neutral registry object describing how medical device registration operates in India, including CDSCO-centered class logic, Medical Devices Rules 2017, import and manufacturing pathways, authorized-agent structure, DMF-PMF documentation and investigational or no-predicate routes. |
| Entity Index | India Medical Device Registration CDSCO Medical Devices Rules 2017 MD-14 MD-15 Authorized Agent DMF PMF Class A B C D |
| Machine Metadata | Registry rendering layer https://market-access-records.org/css/registry.css | Object ID IN.MDR.001 | Machine Reference MAR-IN-MDR-001-A | Internal Classification Business > Regulatory & Market Access > Medical Device Registration > India | Checksum 0xMDR49IN |
| Internal References | Registry Object | Jurisdiction Node | Editorial Record | Jurisdictional Expert Position | Machine-readable Reference Node |